Consensus estimate for Terns Pharmaceuticals Inc. (TERN)’s next quarter EPS at -$0.33

Terns Pharmaceuticals Inc. (NASDAQ: TERN) closed the day trading at $11.83 down -1.17% from the previous closing price of $11.97. In other words, the price has decreased by -$0.14 from its previous closing price. On the day, 650825 shares were traded. TERN stock price reached its highest trading level at $11.97 during the session, while it also had its lowest trading level at $11.07.

Unlock the Hottest Top 10 Penny Stocks Today! Discover Now

Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.

Gain Access to Top 10 Penny Stocks Now!.



For a better understanding of TERN, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 24.70 and its Current Ratio is at 24.70. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 23 when Lu Hongbo bought 758,620 shares for $7.25 per share. The transaction valued at 5,499,995 led to the insider holds 4,340,212 shares of the business.

Vivo Opportunity, LLC bought 758,620 shares of TERN for $5,499,995 on Dec 23. The 10% Owner now owns 4,340,212 shares after completing the transaction at $7.25 per share. On Dec 23, another insider, ORBIMED ADVISORS LLC, who serves as the Director of the company, bought 137,931 shares for $7.25 each. As a result, the insider paid 1,000,000 and bolstered with 4,882,854 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TERN now has a Market Capitalization of 571.85M and an Enterprise Value of 289.94M. Its current Enterprise Value per Revenue stands at 337.47 whereas that against EBITDA is -4.06.

Stock Price History:

Over the past 52 weeks, TERN has reached a high of $14.04, while it has fallen to a 52-week low of $1.46. The 50-Day Moving Average of the stock is 11.58, while the 200-Day Moving Average is calculated to be 8.19.

Shares Statistics:

Over the past 3-months, TERN traded about 398.62K shares per day on average, while over the past 10 days, TERN traded about 607.6k shares per day. A total of 69.78M shares are outstanding, with a floating share count of 35.95M. Insiders hold about 2.10% of the company’s shares, while institutions hold 98.20% stake in the company. Shares short for TERN as of Apr 27, 2023 were 2.87M with a Short Ratio of 2.87M, compared to 2.51M on Mar 30, 2023. Therefore, it implies a Short% of Shares Outstanding of 5.06% and a Short% of Float of 8.19%.

Earnings Estimates

Current recommendations for the stock of the company come from 7 analysts. On average, analysts expect EPS of -$0.34 for the current quarter, with a high estimate of -$0.3 and a low estimate of -$0.42, while EPS last year was -$0.55. The consensus estimate for the next quarter is -$0.33, with high estimates of -$0.26 and low estimates of -$0.43.

Analysts are recommending an EPS of between -$1.09 and -$1.7 for the fiscal current year, implying an average EPS of -$1.35. EPS for the following year is -$1.41, with 7 analysts recommending between -$0.95 and -$1.91.